Dr. Rajesh Ponugupati. EFFICACY AND SAFETY OF DUAL INTERLEUKIN-17A AND INTERLEUKIN-17F INHIBITION WITH BIMEKIZUMAB IN ACTIVE PSORIATIC ARTHRITIS: RESULTS FROM A PHASE 3 RANDOMISED CONTROLLED TRIAL. J Popl Ther Clin Pharmacol. 2016;23(2):237-246. doi:10.53555/am143177